Akums Drugs’ subsidiary, Maxcure Nutravedics Limited, has received a Goods and Services Tax (GST) demand order of ₹53.54 lakh. The order, received on December 24, 2025, includes tax, interest, and penalty. The company believes the demand is unsustainable and intends to file an appeal within the stipulated time.
GST Demand on Subsidiary
Maxcure Nutravedics Limited, a wholly-owned subsidiary of Akums Drugs & Pharmaceuticals Limited, has received a GST demand order. The demand stems from alleged incorrect place of supply declarations by a vendor during GST filings.
Order Details
The total demand amounts to ₹53,53,541. This comprises:
- Tax: ₹28,92,136
- Interest: ₹21,72,192
- Penalty: ₹2,89,213
Company Response
Akums Drugs believes the demand is not justified. The company is evaluating the matter and plans to file an appeal against the order within the prescribed timeframe. They do not foresee any significant impact on their financials or operations.
Source: BSE